Study List


Study List

Clinical Studies

NCT Number Status Brief Title View
NCT00006023 Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00006022 Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer View
NCT00006021 Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma View
NCT00006020 S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia View
NCT00006019 Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia Myelodysplasia Non-Hodgkins Lymphoma Multiple Myeloma Non-small Cell Lung Cancer or Prostate Cancer View
NCT00006018 Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors View
NCT00006017 Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer View
NCT00006016 Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery View
NCT00006015 Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced Recurrent or Metastatic Colorectal Cancer View
NCT00006014 SU5416 in Treating Patients With Malignant Mesothelioma View
NCT00006013 SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma View
NCT00006012 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer View
NCT00006011 Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer View
NCT00006010 Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer View
NCT00006009 Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma View
NCT00006008 Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia View
NCT00006007 LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer View
NCT00006006 Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed View
NCT00006005 Thalidomide in Treating Patients With Gynecologic Sarcomas View
NCT00006004 Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer View
NCT00006003 SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated View
NCT00006002 SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00006001 SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer View
NCT00006000 SU5416 Irinotecan and Cisplatin in Treating Patients With Advanced Solid Tumors View
NCT00005999 Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer View
NCT00005998 Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkins Lymphoma or Hodgkins Disease View
NCT00005997 Rebeccamycin Analogue in Treating Patients With Advanced Liver andor Biliary Cancer View
NCT00005996 SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors View
NCT00005995 AE-941 in Treating Patients With Metastatic Kidney Cancer View
NCT00005994 Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy View
NCT00005993 Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkins Lymphoma Hodgkins Disease or Advanced Breast Cancer View
NCT00005992 Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005991 Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer View
NCT00005990 R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors View
NCT00005989 R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer View
NCT00005988 Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy View
NCT00005987 Filgrastim Compared With Sargramostim Plus Chemotherapy Peripheral Stem Cell Transplantation and Interferon Alfa in Treating Patients With Multiple Myeloma View
NCT00005986 Chemotherapy Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia View
NCT00005985 Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkins Lymphoma or Non-Hodgkins Lymphoma View
NCT00005984 Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia View
NCT00005983 S9927 Radiation Therapy After Surgery Chemotherapy andor Hormone Therapy in Stage II Breast Cancer View
NCT00005982 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma View
NCT00005981 Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer View
NCT00005980 Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer View
NCT00005979 Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer View
NCT00005978 N99-01 Combination Chemotherapy Radiation Therapy and Stem Cell Transplantation in Treating Patients With Neuroblastoma View
NCT00005977 Combination Chemotherapy in Treating Patients With Non-Hodgkins Lymphoma or Acute Lymphocytic Leukemia View
NCT00005976 Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma View
NCT00005975 S9626 Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer View
NCT00005974 Flavopiridol in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma View
NCT00005973 BMS-214662 in Treating Patients With Solid Tumors View
NCT00005972 Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer View
NCT00005971 Flavopiridol in Treating Patients With Metastatic Malignant Melanoma View
NCT00005970 Doxorubicin Hydrochloride Cyclophosphamide and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer View
NCT00005969 Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkins Disease View
NCT00005968 Irofulven in Treating Patients With Stage IV Melanoma View
NCT00005967 Tipifarnib in Treating Patients With Advanced Hematologic Cancer View
NCT00005966 Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer View
NCT00005965 Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix View
NCT00005964 Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II Stage III or Stage IV Non-Hodgkins Lymphoma View
NCT00005963 Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer View
NCT00005962 Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia View
NCT00005961 O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma View
NCT00005960 Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005959 Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkins Lymphoma View
NCT00005958 Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer View
NCT00005957 Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer View
NCT00005956 Biological Therapy in Treating Patients With Advanced Cancer View
NCT00005955 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors View
NCT00005954 Temozolomide in Treating Patients With Brain Metastases View
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors View
NCT00005951 Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma View
NCT00005950 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkins Lymphoma or T-cell Lymphoma View
NCT00005949 Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma View
NCT00005948 Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia View
NCT00005947 Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005946 Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation View
NCT00005945 Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia View
NCT00005944 Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer View
NCT00005943 Gene Therapy in Treating Patients With Metastatic Melanoma View
NCT00005942 Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy View
NCT00005941 Peripheral Stem Cell Transplant White Blood Cell Infusions Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer View
NCT00005940 Radiolabeled BC8 Antibody Busulfan Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission View
NCT00005939 Brachytherapy in Treating Patients With Recurrent Prostate Cancer View
NCT00005938 DX-8951f in Treating Patients With Biliary Cancer View
NCT00005937 Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia View
NCT00005936 Collection of Liver Tissue for Virologic Studies View
NCT00005935 Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia View
NCT00005934 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia View
NCT00005933 Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders View
NCT00005931 SU5416 in Patients With AIDS-Related Kaposis Sarcoma Who Have Not Responded to Treatment View
NCT00005928 Effects of Angiotensin-Converting Enzyme Inhibitor Ramipril Therapy on Blood Vessel Inflammation View
NCT00005927 Study of Adrenal Gland Tumors View
NCT00005926 Gemcitabine Herceptin and Radiation to Treat Cancer of the Pancreas View
NCT00005925 Brain Infusion of Muscimol to Treat Epilepsy View
NCT00005924 Effects of Long-Term Treatment With Valaciclovir Valtrex on Epstein-Barr Virus View
NCT00005923 The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity View
NCT00005922 Conditioning the Placebo Effect and Psoriasis View
NCT00005921 A Study of the Side Effects of L-743872 in Men With Candidal Esophagitis View
NCT00005920 Safety and Effectiveness of Giving L-743872 to Patients With Thrush That Has Not Been Cured With Fluconazole View
NCT00005919 Cause of Pigment Dispersion Syndrome View
NCT00005918 Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients View
NCT00005917 Study of Chediak-Higashi Syndrome View
NCT00005916 PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer View
NCT00005915 A Comparison of Two Anti-HIV Treatment Plans View
NCT00005914 Genetics of Recurrent Early-Onset Depression View
NCT00005912 Voriconazole to Prevent Systemic Fungal Infections in Children View
NCT00005911 Magnetic Resonance Imaging to Study the Normal Eye View
NCT00005910 Laparoscopy to Remove Pancreatic Tumors Insulinomas View
NCT00005909 Study of Alkaptonuria View
NCT00005908 Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer View
NCT00005907 Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers View
NCT00005906 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis View
NCT00005905 Leptin to Treat Lipodystrophy View
NCT00005903 Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor GDNF to Treat Progressive Supranuclear Palsy View
NCT00005902 Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease View
NCT00005901 Pamidronate to Treat Osteogenesis Imperfecta in Children View
NCT00005900 Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation View
NCT00005898 Phase III Study of Total Body Irradiation Cyclophosphamide and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconis Anemia View
NCT00005896 Phase I Pilot Study of CD34 Enriched Fanconis Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconis Anemia View
NCT00005893 Study of Allogeneic Bone Marrow Transplantation Using Matched Related Donors in Patients With Nonmalignant Hematologic Disorders View
NCT00005892 Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconis Anemia View
NCT00005891 Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconis Anemia View
NCT00005890 Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock View
NCT00005889 Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion View
NCT00005888 Study of the Relationship Between Feeding and Late Onset Sepsis andor Necrotizing Enterocolitis in Low Birth Weight Infants View
NCT00005887 Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases View
NCT00005886 Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer View
NCT00005884 Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer View
NCT00005883 Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke View
NCT00005881 Quality of Life in Children Treated for Cancer View
NCT00005880 Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia View
NCT00005879 LY353381 in Preventing Breast Cancer in Women With Hyperplasia View
NCT00005878 Celecoxib to Prevent Cancer in Patients With Barretts Esophagus View
NCT00005877 Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer View
NCT00005876 Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery View
NCT00005875 Nitrocamptothecin in Treating Patients With Metastatic Melanoma View
NCT00005874 Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas View
NCT00005873 Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer View
NCT00005872 Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer View
NCT00005871 Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer View
NCT00005870 Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas View
NCT00005869 Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer View
NCT00005868 Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer View
NCT00005867 Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkins Lymphoma View
NCT00005866 S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia View
NCT00005865 Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer View
NCT00005864 Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer View
NCT00005863 Combination Chemotherapy With or Without Filgrastim andor Tretinoin in Treating Patients With Acute Myeloid Leukemia View
NCT00005862 SU5416 in Treating Patients With Advanced Metastatic or Recurrent Soft Tissue Sarcomas View
NCT00005861 Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer View
NCT00005860 Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum View
NCT00005859 Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma View
NCT00005858 LMB-9 Immunotoxin in Treating Patients With Advanced Colon Breast Non-small Cell Lung Bladder Pancreatic or Ovarian Cancer View
NCT00005857 Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy View
NCT00005856 Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme View
NCT00005855 Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma View
NCT00005854 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer View
NCT00005853 Biological Therapy in Treating Patients With Myelodysplastic Syndrome View
NCT00005852 Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant View
NCT00005851 Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer View
NCT00005850 Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer View
NCT00005849 Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB Stage IV or Recurrent Non-small Cell Lung Cancer View
NCT00005848 R115777 in Treating Patients With Progressive Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005847 Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005845 Tipifarnib in Treating Patients With Myelodysplastic Syndromes View
NCT00005844 Oxaliplatin in Treating Children With Advanced Solid Tumors View
NCT00005843 R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer View
NCT00005842 Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer View
NCT00005841 Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma View
NCT00005840 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer View
NCT00005839 Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor View
NCT00005838 Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery View
NCT00005837 Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer View
NCT00005836 Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy View
NCT00005835 N99-02 Melphalan and Buthionine Sulfoximine View
NCT00005834 S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma View
NCT00005833 S9923 R115777 in Treating Patients With Advanced Colorectal Cancer View
NCT00005832 S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer View
NCT00005831 Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer View
NCT00005830 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer View
NCT00005829 Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia View
NCT00005828 Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005827 Genistein in Treating Patients With Stage II Stage III or Stage IV Prostate Cancer View
NCT00005826 Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme View
NCT00005825 Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer View
NCT00005824 Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma View
NCT00005823 Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome View
NCT00005822 SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer View
NCT00005821 Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer View
NCT00005820 Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy View
NCT00005819 Combination Chemotherapy in Treating Patients With Advanced Solid Tumors View
NCT00005818 SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer View
NCT00005817 Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer View
NCT00005816 Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer View
NCT00005815 Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma View
NCT00005814 Cetuximab Cisplatin and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer View
NCT00005813 Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme View
NCT00005812 Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma View
NCT00005811 Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment View